Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 10, Pages 2843
Publisher
MDPI AG
Online
2021-05-11
DOI
10.3390/molecules26102843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Boron Chemistry for Medical Applications
- (2020) Fayaz Ali et al. MOLECULES
- Cardiovascular effects and safety of (non-aspirin) NSAIDs
- (2020) Anne-Marie Schjerning et al. Nature Reviews Cardiology
- Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells
- (2020) Antonio Buzharevski et al. Scientific Reports
- Non-Classical Phenyl Bioisosteres as Effective Replacements in a Series of Novel Open Source Antimalarials
- (2020) Edwin Tse et al. JOURNAL OF MEDICINAL CHEMISTRY
- Carboranyl analogues of celecoxib with potent cytostatic ability against human melanoma and colon cancer cell lines
- (2019) Antonio Buzharevski et al. ChemMedChem
- Half- and mixed-sandwich metallacarboranes for potential applications in medicine
- (2019) Marta Gozzi et al. PURE AND APPLIED CHEMISTRY
- Mitochondrial Dynamics Impairment in Dexamethasone-Treated Neuronal Cells
- (2019) Wilasinee Suwanjang et al. NEUROCHEMICAL RESEARCH
- γ-Secretase and its modulators: Twenty years and beyond
- (2019) Weiming Xia NEUROSCIENCE LETTERS
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- Tuning Properties for Blood–Brain Barrier Permeation: A Statistics-Based Analysis
- (2019) Maria Dichiara et al. ACS Chemical Neuroscience
- Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
- (2017) Ping Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Why Did Tarenflurbil Fail in Alzheimer's Disease?
- (2017) Bruno P. Imbimbo JOURNAL OF ALZHEIMERS DISEASE
- Interactions of Boron Clusters and their Derivatives with Serum Albumin
- (2017) Tomasz M. Goszczyński et al. Scientific Reports
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?
- (2016) Matthew G. Bursavich et al. JOURNAL OF MEDICINAL CHEMISTRY
- nido-Dicarbaborate Induces Potent and Selective Inhibition of Cyclooxygenase-2
- (2015) Wilma Neumann et al. ChemMedChem
- Carrier Mediated Distribution System (CAMDIS): A new approach for the measurement of octanol/water distribution coefficients
- (2015) Bjoern Wagner et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma
- (2015) Ersoy Oksuz et al. JOURNAL OF NEURO-ONCOLOGY
- Carbaboranes – more than just phenyl mimetics
- (2015) René Frank et al. PURE AND APPLIED CHEMISTRY
- Boron clusters in medicinal chemistry: perspectives and problems
- (2015) Detlef Gabel PURE AND APPLIED CHEMISTRY
- The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
- (2014) Shane M. Wilkinson et al. ACS Chemical Neuroscience
- Lessons from a Failed γ-Secretase Alzheimer Trial
- (2014) Bart De Strooper CELL
- Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings
- (2014) David B. Henley et al. CURRENT MEDICAL RESEARCH AND OPINION
- Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)
- (2013) Raymond L. Moss APPLIED RADIATION AND ISOTOPES
- Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease
- (2013) Christina J. Crump et al. BIOCHEMISTRY
- A fast growing spectrum of biological functions of γ-secretase in development and disease
- (2013) Nathalie Jurisch-Yaksi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extremely Electron-Rich, Boron-Functionalized, Icosahedral Carborane-Based Phosphinoboranes
- (2012) Alexander M. Spokoyny et al. ORGANOMETALLICS
- Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3
- (2011) Hiroaki Honjo et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cells
- (2011) Ellen L. Crossley et al. CHEMICAL COMMUNICATIONS
- Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
- (2011) Matthias Scholz et al. CHEMICAL REVIEWS
- Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds
- (2011) Fatiah Issa et al. CHEMICAL REVIEWS
- Attenuated Aβ42Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds
- (2011) Benedikt Kretner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Asborin Inhibits Aldo/Keto Reductase 1A1
- (2010) Matthias Scholz et al. ChemMedChem
- Monocarboxylate transport in human corneal epithelium and cell lines
- (2009) Kati-Sisko Vellonen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels
- (2009) Samer O. Abdul-Hay et al. JOURNAL OF NEUROCHEMISTRY
- Permeability of the Blood-Brain Barrier to a Rhenacarborane
- (2009) P. M. Hawkins et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Substrate-targeting γ-secretase modulators
- (2008) Thomas L. Kukar et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation